• Bracing for the biosimilar wave Nature Reviews Drug Discovery
    March 14, 2017
    The regulatory uncertainty around biosimilars in the United States is finally lifting, just months after the first biosimilar monoclonal antibody hit the US market.
PharmaSources Customer Service